Imiquimod
Product Images NDC 52549-4145

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Imiquimod (NDC 52549-4145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Taro Pharmaceutical Industries Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Imiquimod 01)

Chemical structure of Imiquimod, showing the molecular arrangement of its atoms and bonds as a two-dimensional skeletal formula.*

FDA Label Image

Figure 1 (Imiquimod 02)

A flowchart depicting the enrollment and treatment outcomes of 209 subjects in a study comparing Imiquimod Cream and Vehicle. It shows the number of participants who completed treatment or withdrew, and their clear or not clear status after 16 weeks, plus follow-up results at 12 weeks. The chart includes notes about subjects lost to follow-up or with recurrences.*

FDA Label Image

Principal Display Panel (24 Packet Carton)

Packaging label for Imiquimod Cream 5% by Taro Pharmaceutical Industries Ltd. The label indicates 24 single-use packets, each with a net weight of 0.25 g and a total box weight of 6 g. The label states the product is for dermatologic use only, not for ophthalmic use, and is Rx only. Storage instructions specify 4°-25°C with avoidance of freezing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.